Loading...
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma
Based on available data, most multiple myeloma patients have residual myeloma cells in their autologous hematopoietic progenitor cells (HPC) grafts during collection for autologous stemcell transplant. However, available literature is based on older induction regimens, e.g., adriamycin and dexametha...
Saved in:
| Published in: | Bone Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6740327/ https://ncbi.nlm.nih.gov/pubmed/29728700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0170-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|